Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,159 across all filing types
Latest filing 2020-11-18 AGM Information
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
CEO's presentation to AGM and market update 31 pages 1.3MB
AGM Information Classification · 95% confidence The document is titled 'CEO Presentation to AGM' and contains detailed slides with forward-looking statements, agenda items, updates on cash position, clinical projects, patents, and funding possibilities. It is clearly a presentation given at the Annual General Meeting (AGM) of the company. The content is consistent with investor presentations typically shared during AGMs, focusing on business updates, strategy, and future outlook rather than a formal annual report or financial statements. The document length is substantial (15,000 characters), indicating it is the presentation itself, not just an announcement of a report. Therefore, the appropriate classification is AGM Information (AGM-R).
2020-11-18 English
Results of Annual General Meeting 2 pages 561.2KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement titled 'Results of Annual General Meeting held on 19 November 2020' for Living Cell Technologies Limited. It provides detailed voting results for resolutions passed at the AGM, including adoption of the remuneration report, re-election of a director, appointment of auditor, and approval of a placement facility. The document references ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, which pertain to disclosure of voting results. The content is focused on the official results of shareholder votes at the AGM, not the AGM materials themselves or the full annual report. The document length is short (2496 characters) and it is clearly a formal announcement of voting outcomes. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-11-18 English
Quarterly Activity Report and Appendix 4C 7 pages 786.1KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly Cash Flow Report 30 September 2020' and is an ASX announcement. It contains detailed quarterly cash flow statements, including operating, investing, and financing activities, as well as cash balances and reconciliation. The report covers the quarter ended 30 September 2020, providing substantive financial data and analysis. The length of the document (15,000 characters) and the presence of detailed financial tables confirm it is a full quarterly financial report rather than a brief announcement or certification. The Appendix 4C is a recognized quarterly report format under ASX Listing Rules, which aligns with the definition of an Interim / Quarterly Report (IR). Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q1 2021
2020-10-27 English
2020 Annual General Meeting 17 pages 1.5MB
AGM Information Classification · 100% confidence The document is an ASX announcement from Living Cell Technologies Limited regarding their 2020 Annual General Meeting (AGM). It includes details such as the date and time of the AGM, virtual meeting arrangements due to the COVID-19 pandemic, instructions on how shareholders can attend and vote, and the agenda items including consideration of the financial report, adoption of the remuneration report, re-election of a director, appointment of auditor, and approval of a placement facility. The document is clearly a notice and information related to the AGM rather than the actual AGM report or minutes. It contains no financial statements or detailed financial analysis but rather logistical and procedural information for shareholders about the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2020-10-18 English
Annual Report to shareholders 43 pages 1.2MB
Annual Report Classification · 100% confidence The document is titled '2019 - 2020 ANNUAL REPORT' and contains detailed sections typical of an annual report, including Chairman's and CEO's messages, significant events, advisory boards, directors' report, auditor's independence declaration, consolidated financial statements, notes to the financial statements, directors' declaration, and independent auditor's report. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The content includes comprehensive financial data and corporate governance information for the fiscal year 2019-2020. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2020-10-18 English
Appendix 4G and Corporate Governance Statement 23 pages 620.5KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G' and references ASX Listing Rules 4.7.3 and 4.10.3, which relate to corporate governance disclosures that must accompany the annual report. It includes a detailed key to disclosures against the ASX Corporate Governance Council Principles and Recommendations for the financial year ended 30 June 2020. The document is a corporate governance statement or a compliance checklist related to governance practices, approved by the board and lodged with ASX alongside the annual report. It does not contain financial statements or management discussion of financial results but focuses on governance practices and compliance disclosures. This type of document aligns with Governance Information (CGR) filings, which detail the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and content confirm it is a full governance disclosure rather than a brief announcement or a certification. Therefore, the appropriate classification is CGR.
2020-10-18 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.